Rhodin, K. E., Gaughan, E. M., Raman, V., Salama, A. K., Hanks, B. A., Shah, R., … Beasley, G. M. (2021). Complete Pathologic Response Predicts Disease-Free Survival for Melanoma Patients Undergoing Neoadjuvant Therapy. In JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (Vol. 233, pp. S246–S246).

Rhodin, Kristen E., Elizabeth M. Gaughan, Vignesh Raman, April K. Salama, Brent A. Hanks, Riddhishkumar Shah, Douglas S. Tyler, Craig L Jr Slingluff, and Georgia M. Beasley. “Complete Pathologic Response Predicts Disease-Free Survival for Melanoma Patients Undergoing Neoadjuvant Therapy.” In JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 233:S246–S246, 2021.

Rhodin KE, Gaughan EM, Raman V, Salama AK, Hanks BA, Shah R, et al. Complete Pathologic Response Predicts Disease-Free Survival for Melanoma Patients Undergoing Neoadjuvant Therapy. In: JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS. 2021. p. S246–S246.

Rhodin, Kristen E., et al. “Complete Pathologic Response Predicts Disease-Free Survival for Melanoma Patients Undergoing Neoadjuvant Therapy.” JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, vol. 233, no. 5, 2021, pp. S246–S246.

Rhodin KE, Gaughan EM, Raman V, Salama AK, Hanks BA, Shah R, Tyler DS, Slingluff CLJ, Beasley GM. Complete Pathologic Response Predicts Disease-Free Survival for Melanoma Patients Undergoing Neoadjuvant Therapy. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS. 2021. p. S246–S246.